Performance of everolimus-eluting stents: Pooled analysis from the SPIRIT trials

Journal of Interventional Cardiology

Volumn 22, Issue SUPPL. 1, 2009, Pages

  Miu, Raymond ^a   Serruys, Patrick W ^b   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; PACLITAXEL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ASIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EUROPE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; RISK REDUCTION; SINGLE BLIND PROCEDURE; STENT THROMBOSIS; UNITED STATES;

EID: 65649120357     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00452.x     Document Type: Article

References (19)

1. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323. (Pubitemid 37186209)
2. Stone GW, Ellis SG, Cox DA, et al. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004 350 : 221 231. (Pubitemid 38067635)
3. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007 356 : 998 1008. (Pubitemid 46376800)
4. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: A collaborative network meta-analysis. Lancet 2007 370 : 937 948. (Pubitemid 47393576)
5. Morice MC, Colombo A, Meier B, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY trial: A randomized controlled trial. JAMA 2006 295 : 895 904.
6. Stone GW, Ellis SG, Cannon L, et al., the TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005 294 : 1215 1223. (Pubitemid 41352109)
7. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007 115 : 2435 2441. (Pubitemid 46717966)
8. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007 369 : 667 678. (Pubitemid 46281313)
9. Marx SO, Marks AR. Bench to bedside: The development of rapamycin and its application to stent restenosis. Circulation 2001 104 : 852 855. (Pubitemid 32778031)
10. Simon C, Palmaz JC, Sprague EA. Influence of topography on endothelialization of stents: Clues for new designs. J Long Term Eff Med Implants 2000 10 : 143 151. (Pubitemid 30387812)
11. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008 52 : 333 342.
12. Serruys PW, Ong ATL, Piej JJ, et al. A randomised comparison of a durable polymer everolimus-eluting coronary stent with a bare metal coronary stent: The Spirit FIRST trial. EuroIntervention 2005 1 : 58 65.
13. Tsuchida K, Piek JJ, Neuman FJ, et al. One year results of a durable polymer everolimus eluting stent in de novo coronary narrowings (the SPIRIT FIRST trial). EuroIntervention 2005 1 : 266 272.
14. Serruys PW, Ruygrok P, Neuzner J, et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. Euro-Intervention 2006 2 : 286 294.
15. Ruygrok PN, Desaga M, Van Den Branden F, et al. One year clinical follow-up of the XIENCE V everolimus eluting stent system in the treatment of patients with de novo native coronary artery lesions. The SPIRIT II study. EuroIntervention 2007 3 : 315 320.
16. Stone GW, Midei M, Newman W, et al., the SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial. JAMA 2008 299 : 1903 1913.
17. Cutlip DE, Windecker S, Mehran R, et al., the Academic Research Consortium. Clinical endpoints in coronary stent trials - a case for standardized definitions. Circulation 2007 115 : 2344 2351. (Pubitemid 46685903)
18. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998 352 : 673 681. (Pubitemid 28398701)
19. Kirtane AJ, Ellis SG, Dawkins KD, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: Pooled analysis from 5 randomized trials. J Am Coll Cardiol 2008 51 : 708 715.